Chloro(1,3-dimesitylimidazol-2-ylidene)copper(I)>97.0%(T)200mg

2-(Azetidin-3-yloxy)-3,5-dichloropyridine, 98%, 250mg

1,4-Dihydroxy-2,6-dimethoxybenzene, 97.0%, 250mg

3-BROMO-6-CYCLOPROPYLPYRIDAZINE HYDROBROMIDE, 95.0%, 1g

5h,6h,7h-Pyrazolo[3,2-b][1,3]oxazine-2-carbaldehyde, 98+%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(2-(trifluoromethyl)phenyl)propanoic acid, 95%, 1g

Ethyl 1-(4-bromophenyl)-5-methyl-1H-1,2,3-triazole-4-carboxylate, 97.0%, 5g

2-[(4,5-Dihydro-1H-imidazol-2-yl)amino]ethan-1-ol hydroiodide, 80.0%, 250mg

(S)-1-(4-Chloro-2-methylphenyl)ethanamine hydrochloride, 95.0%, 250mg

2-Chloromethyl-pyrazine, 95.0%, 1g

Chromatography-Papers Whatman® 17CHR Thickness 0,92 mm, 57 x 46 cm, 25 sheet(s), 25 Blatt

2-Hexanone>98.0%(GC)500mL

4-(1H-pyrazol-4-yl)aniline, 95.0%, 250mg